These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15864423)

  • 1. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
    Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
    Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
    Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
    Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E; Iacobone M; Sebag F; Henry JF
    Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
    Takami H; Ito K
    Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased calcitonin level in thyroid nodules without medullary carcinoma.
    Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
    Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature.
    Tranchida P; Estigarribia J; Sethi S; Giorgadze T
    Diagn Cytopathol; 2011 Sep; 39(9):641-6. PubMed ID: 20949456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
    Bugalho MJ; Santos JR; Sobrinho L
    J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
    Karges W
    Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine serum calcitonin measurement in the evaluation of thyroid nodules.
    Elisei R
    Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):941-53. PubMed ID: 19041824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary thyroid carcinoma in a patient with Hashimoto's thyroiditis diagnosed by calcitonin washout from a thyroid nodule.
    Mousa U; Gursoy A; Ozdemir H; Moray G
    Diagn Cytopathol; 2013 Jul; 41(7):644-6. PubMed ID: 22102446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine measurement of plasma calcitonin in nodular thyroid diseases.
    Vierhapper H; Raber W; Bieglmayer C; Kaserer K; Weinhäusl A; Niederle B
    J Clin Endocrinol Metab; 1997 May; 82(5):1589-93. PubMed ID: 9141554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.
    Giovanella L; Maffioli M; Suriano S; Dorizzi RM
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):852-3. PubMed ID: 19863575
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin.
    Medina-Franco H; Herrera MF; López G; Tielve-Campillo M; Sierra M; Lozano-Salazar RR; González O
    Rev Invest Clin; 2001; 53(3):212-7. PubMed ID: 11496707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spuriously elevated plasma calcitonin in a patient with a thyroid nodule not associated with medullary thyroid carcinoma.
    Lamb EJ; Heddle RM; Ellis A
    Postgrad Med J; 1999 May; 75(883):289-90. PubMed ID: 10533634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid cancer with undetectable serum calcitonin.
    Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
    J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.